Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:182:5-12.
doi: 10.1159/000349962. Epub 2013 May 13.

Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)

Peter A McCullough  1 , Josee Bouchard, Sushrut S Waikar, Edward D Siew, Zoltan H Endre, Stuart L Goldstein, Jay L Koyner, Etienne Macedo, Kent Doi, Salvatore Di Somma, Andrew Lewington, Ravi Thadhani, Raj Chakravarthi, Can Ice, Mark D Okusa, Jacques Duranteau, Peter Doran, Li Yang, Bertrand L Jaber, Shane Meehan, John A Kellum, Michael Haase, Patrick T Murray, Dinna Cruz, Alan Maisel, Sean M Bagshaw, Lakhmir S Chawla, Ravindra L Mehta, Andrew D Shaw, Claudio Ronco
Affiliations

Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)

Peter A McCullough et al. Contrib Nephrol. 2013.

Abstract

Detection of acute kidney injury is undergoing a dynamic revolution of biomarker technology allowing greater, earlier, and more accurate determination of diagnosis, prognosis, and with powerful implication for management. Biomarkers can be broadly considered as any measurable biologic entity or process that allows differentiation between normal function and injury or disease. The ADQI (Acute Dialysis Quality Initiative) had its Ninth Consensus Conference dedicated to synthesis and formulation of the existing literature on biomarkers for the detection of acute kidney injury in a variety of settings. In the papers that accompany this summary, ADQI workgroups fully develop key concepts from a summary of the literature in the domains of early diagnosis, differential diagnosis, prognosis and management, and concurrent physiologic and imaging measures.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The AKIN and RIFLE definitions and grading for AKI.
Fig. 2
Fig. 2
Depiction of damage and functional markers in the detection of AKI. Reproduced with permission from ADQI [15].
Fig. 3
Fig. 3
Recognition of AKI and clinical responses. Adapted from KDIGO [1].
See this image and copyright information in PMC

References

    1. KDIGO. AKI Guidelines. Summary of recommendation statements. Kidney Int Suppl. 2012;2:8–12. - PMC - PubMed
    1. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–1917. - PubMed
    1. Kellum JA, Bellomo R, Ronco C. Acute Dialysis Quality Initiative (ADQI): methodology. Int J Artif Organs. 2008;31:90–93. - PubMed
    1. Boudonck KJ, Rose DJ, Karoly ED, Lee DP, Lawton KA, Lapinskas PJ. Metabolomics for early detection of drug-induced kidney injury: review of the current status. Bioanalysis. 2009;1:1645–1663. - PubMed
    1. McCullough PA, Chinnaiyan KM, Gallagher MJ, Colar JM, Geddes T, Gold JM, Trivax JE. Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton) 2011;16:194–199. - PubMed

Publication types